News
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Conference Call August 5, 2025 8:00 AM ETCompany ParticipantsBen R.
Recursion Pharmaceuticals reported its second-quarter 2025 earnings with revenue significantly surpassing expectations, while earnings per share (EPS) fell short. The company posted an actual EPS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback